Leqembi Approved for Alzheimer’s Treatment in the UAE | iPharmaCenterEisai and Biogen have announced that the United Arab Emirates (UAE) Ministry of Health and Prevention has granted approval for Leqembi...
South Korea | MFDS Drug Approvals | Updates | 2024 | iPharmaCenterLEQEMBI (Lecanemab) Gains Approval in South Korea for Alzheimer’s Disease Treatment EiSai and Biogen have announced that South Korea's...
South Korea Drug approvals | Updates | MFDS | iPharmaCenterEisai submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety (MFDS) to seek approval for...